Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using a cognitive app to assess brain tumor patients' quality of life

Official title: Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Run by Baptist Health South Florida · NCT05504681 · Data updated 2026-11-12

This study tests whether a brain health app can help doctors understand the quality of life and cognitive function of adults treated for brain tumors at the Miami Cancer Institute.

More Neurocognitive Disorders trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorBaptist Health South Florida
Academic / other
Locations1 site (Miami, Florida)
StatusRecruiting
StartedNovember 30, 2021
Main results expectedApril 2030
Study endsApril 2032
Registry record updatedMay 19, 2026
Trial IDNCT05504681 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult patients (18+) with central nervous system tumors who are undergoing treatment and have a life expectancy of at least six months.

Probably not a fit

Patients receiving radiotherapy for functional diseases or those who are under 18, pregnant, or incarcerated may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry study aims to evaluate the feasibility of using the Brainlab Cognition app in a neuro-oncology clinic to assess neurocognitive function among patients with central nervous system tumors. It will also explore the integration of electronically reported quality of life parameters into clinical practice. The study will involve adult patients treated for brain tumors at the Miami Cancer Institute, focusing on their experiences and outcomes post-treatment. Data will be collected prospectively to inform future clinical applications.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of neurocognitive function and quality of life in brain tumor patients, leading to improved patient care.

How similar studies have gone: While the integration of cognitive assessments in clinical settings is being explored, this specific approach using the Brainlab Cognition app is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI)
2. Life expectancy ≥ 6 months
3. Willingness to participate in ongoing registration study

Exclusion Criteria:

1. Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.)
2. Pediatric patients (\<18 years old), pregnant women, and prisoners.

Where it's running

  • Miami Cancer Institute
    Miami, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.